FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Aging, Premature
Washington University School of MedicineSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Aging, Premature cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dasatinib Washington University School of Medicine | Phase 2 | CCC |
Eslicarbazepine Acetate Centre Hospitalier Saint Joseph Saint Luc de Lyon | D |
Same molecule, other indications
FLAVONE, 3,3',4',5,7-PENTAHYDROXY- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →